Actively Recruiting

Phase 2
Phase 3
Age: 45Years - 55Years
FEMALE
Healthy Volunteers
NCT03916978

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Led by Genesis Athens Clinic · Updated on 2024-12-27

100

Participants Needed

1

Research Sites

375 weeks

Total Duration

On this page

Sponsors

G

Genesis Athens Clinic

Lead Sponsor

N

National and Kapodistrian University of Athens

Collaborating Sponsor

AI-Summary

What this Trial Is About

Autologous PRP intra ovarian infusion may restore ovarian function, may promote folliculogenesis and may improve hormonal profile of women in menopause.

CONDITIONS

Official Title

Autologous PRP Intra Ovarian Infusion to Restore Ovarian Function in Menopausal Women

Who Can Participate

Age: 45Years - 55Years
FEMALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 45-55 years old
  • Amenorrhea for at least 12 months
  • Discontinuation of any complementary/adjuvant treatment including hormone replacement, acupuncture, and botanotherapy, for at least three months prior to recruitment
  • Willing to comply with study requirements
Not Eligible

You will not qualify if you...

  • Any pathological disorder related to reproductive system anatomy
  • Previous POI diagnosis
  • Abnormal karyotype
  • Endometriosis
  • Adenomyosis
  • Fibroids and adhesions
  • Infections in reproductive system
  • Current or previous diagnosis of reproductive system cancer
  • History of familiar cancer in reproductive system
  • Severe male factor infertility
  • Prior referral for PGT
  • Ovarian inaccessibility
  • Endocrinological disorders (Hypothalamus-Pituitary disorders, thyroid dysfunction, diabetes mellitus, metabolic syndrome)
  • BMI >30 kg/m2 or BMI <18.5 kg/m2
  • Systematic autoimmune disorders

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Genesis AC

Athens, Greece, 15232

Actively Recruiting

Loading map...

Research Team

M

Mara Simopoulou, PhD

CONTACT

A

Agni Pantou, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here